NCT00800540View on ClinicalTrials.gov

Circadian Ocular Perfusion Pressure and Ocular Blood Flow

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Glaucoma
Interventions
DRUG

Brinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspension

Fixed combination ophthalmic suspension

DRUG

Brimonidine 20 mg/ml/Timolol 5 mg/ml eye drops solution

Fixed combination ophthalmic solution

Trial Locations (1)

76134

Contact Alcon Call Center at 1-888-451-3937 For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00800540 - Circadian Ocular Perfusion Pressure and Ocular Blood Flow | Biotech Hunter | Biotech Hunter